South Korea Plasma Fractionation Market Size & Outlook
Related Markets
South Korea plasma fractionation market highlights
- The South Korea plasma fractionation market generated a revenue of USD 586.9 million in 2024 and is expected to reach USD 933.4 million by 2030.
- The South Korea market is expected to grow at a CAGR of 8.1% from 2025 to 2030.
- In terms of segment, immunoglobulins was the largest revenue generating product in 2024.
- Immunoglobulins is the most lucrative product segment registering the fastest growth during the forecast period.
Plasma fractionation market data book summary
| Market revenue in 2024 | USD 586.9 million |
| Market revenue in 2030 | USD 933.4 million |
| Growth rate | 8.1% (CAGR from 2025 to 2030) |
| Largest segment | Immunoglobulins |
| Fastest growing segment | Immunoglobulins |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Albumin, Coagulation Factors, Protease inhibitors, Immunoglobulins |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, CSL Ltd, Takeda Pharmaceutical Co Ltd, Biotest AG ADR, Octapharma AG, Kedrion Biopharma, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Bio Products Laboratory, Intas Pharmaceuticals |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.6% of the global plasma fractionation market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China plasma fractionation market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,179.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasma Fractionation Market Scope
Plasma Fractionation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Intas Pharmaceuticals | View profile | 1001-5000 | Ahmedabad, Gujarat, India, Asia | https://intaspharma.com/ |
| Bio Products Laboratory | View profile | 501-1000 | Kingdom City, Missouri, United States, North America | http://www.bplgroup.com/ |
| LFB (Laboratoire Français du Fractionnement et des Biotechnologies) | View profile | 1001-5000 | Courceboeufs, Pays de la Loire, France, Europe | http://www.groupe-lfb.com |
| Kedrion Biopharma | View profile | 1001-5000 | Fort Lee, New Jersey, United States, North America | https://www.kedrion.com/ |
| Octapharma AG | View profile | 10001+ | Lachen, Schwyz, Switzerland, Europe | http://www.octapharma.com/en.html |
| Biotest AG ADR | View profile | 2426 | Landsteinerstrasse 5, Dreieich, Germany, 63303 | https://www.biotest.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
South Korea plasma fractionation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasma fractionation market will help companies and investors design strategic landscapes.
Immunoglobulins was the largest segment with a revenue share of 68.5% in 2024. Horizon Databook has segmented the South Korea plasma fractionation market based on albumin, coagulation factors, protease inhibitors, immunoglobulins covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea plasma fractionation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea plasma fractionation market databook
-
Our clientele includes a mix of plasma fractionation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea plasma fractionation market , including forecasts for subscribers. This country databook contains high-level insights into South Korea plasma fractionation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea plasma fractionation market size, by product, 2018-2030 (US$M)
South Korea Plasma Fractionation Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
